Booth No. : A31

Presentation Representative : Masaru Tomita

Person in Charge of the Project : Mayuko Takatou

SFC BIO
Solution for a new type of muscular dystrophy

107_e161_attribute138_ORFロゴ.001

Muscular dystrophy is a neuromuscular disorder that causes muscle weakness and hypotonia, hence it is known as a remediless rare disease. This research takes advantage of the leading-edge Metabolome analysis technologies, and aims to develop drugs for treatment, since development of medical treatments and supplies against rare diseases can not advance at a quick pace. We are conducting comprehensive metabolic analysis and are analyzing amino acids and fatty acids contained in the tissues of a muscular dystrophy model mouse, to clarify novel pathogenetic mechanisms.

http://bio.sfc.keio.ac.jp/